Introduction
Vertebrate non-muscle and smooth muscle myosin molecules, like almost all other myosins, have two heads, each of which carries an essential and a regulatory light chain. The rest of the molecule forms a rod-like tail, and it is these tails which are responsible for the self-assembly of myosin at physiological ionic strength to form filaments. The heads project from the resulting filaments, forming the crossbridges that interact with actin. Phosphorylation of the regulatory light chains by a Ca?'-dependent myosin light chain kinase switches on the cyclic force-generating interaction of the cross-bridges with actin. This same phosphorylation event also appears to regulate the state of assembly of these myosins (reviewed by Citi & Kendrick-Jones, 1 9 8 7~) .
I n vitro, the myosins can exist in three major forms, as an assembly-blocked monomer, with the tail folded at two bend regions to form a compact conformation (sedimentation coefficient 1 OS), or as an assembly-competent monomer with a straight tail (sedimentation coefficient 6S), or as a filament (Trybus et a/.. 1982; Onishi & Wakabayashi, 1982; Craig et at., 1983 ) (see Fig. 1 ). Regulatory light chain phosphorylation appears to regulate filament assembly in vitro by changing the position of the equilibrium between the two monomer conformations. It is possible that a similar dynamic equilibrium between these states exists in vivo. This would allow a continuous reorganization of the myosin filaments, so that in a non-muscle cell the contractile machinery for a motile event such as cytokinesis could be assembled/disassembled, or in a smooth muscle cell optimum overlap of myosin filamcnts with actin filaments at different cell lengths could be maintained. Here we will briefly examine the evidence to support this speculation, and summarize some of our recent data on the regulation of key steps of myosin filament assembly by light chain phosphorylation.
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The elementuty steps of assembly: a simple model for the assembly pathway I n vitro. at physiological ionic strength, smooth muscle (gizzard) and non-muscle (thymus, brush border) myosins exhibit critical concentrations for assembly into filaments (Kendrick-Jones et al., 1987) , indicating that the filaments form by a nucleation-condensation mechanism broadly analogous to that which determines the assembly of actin, tubulin, and skeletal muscle myosin. To study the assembly of the smooth and non-muscle myosins, we have assumed that the simple steps shown in Fig. 1 constitute the assembly pathway.
In this simple monomer-filament equilibrium scheme, fila- to consist of 6 s and 1 0 s species in rapid equilibrium (Trybus & Lowey, 1984) . Driving this equilibrium over towards the 6 s species results in filament assembly (see below). Additional evidence that filaments are built from 6s molecules derives from the observation that the folded (10s) form of smooth muscle myosin traps ADP and inorganic phosphate in its active sites : such trapping is not detectable on myosin filaments , suggesting that 10s molecules do not associate stably with myosin filaments. Furthermore, the 10s species is stable in solution at high concentration at physiological ionic strength, whereas the 6 s myosin species is highly unstable, being present at equilibrium in only very low amounts under these conditions (as about 1% of the free monomer population). The myosin molecule preferentially adopts under physiological conditions either the 10s monomer conformation, or else joins a filament. At present we do not know whether dimerization or higher oligomerization (Pollard, 1982) reactions of myosin molecules lie on the assembly pathway. Davis et at.
( 1 982) have argued that the assembly of skeketal muscle myosin occurs via an initial parallel dimerization of myosin molecules. For smooth muscle myosin, there is good evidence that the 43-nm-overlapped tail-to-tail (antiparallel) dimerization of 6s molecules is a strongly favoured mode of intermolecular binding (Kendrick-Jones et al., 197 1; Cross & Vanderkerckhove, 1986 ). Dimerization of 10s molecules to a 15s species at low ionic strength has also been described (Trybus & Lowey, 1984; Onishi & Wakabayashi, 1984) . Unfolding of such dimers (Trybus & Lowey, 1984) could also lie on the assembly pathway. Both putative dimer species are expected to be transient intermediates which will occur at only very low concentrations at equilibrium, and have not yet been detected under these conditions. The virtue of the simple scheme in Fig. 1 is that it produces specific predictions about the kinetics of assembly. Determination of these will allow us to test whether other kinetic species are involved.
Operation of the pathway: how does a myosin filament grow?
Myosin filaments differ from either actin or tubulin in that they have two equivalent ends: both actin and tubulin have non-equivalent ends, the ends having different critical concentrations for protomer addition or loss (Pollard & Cooper, 1986) . Myosin filament growth could occur symmetrically from the filament ends, or from the body of the filament, or both. In each case, the exchange of molecules could be strictly sequential (only one allowed site for a molecule to add to at any one time), or there could be several exchangeable sites at any instant. The only myosin so far analysed in any detail has been that from skeletal muscle, which was Vol. 16 studied using a pressure-jump technique to perturb the monomer-filament equilibrium. The results obtained were consistent with a strongly sequential addition or loss of protomers occurring only at the filament ends (Davis, 1981a,b) . In the case of vertebrate smooth and non-muscle myosins, assembly and disassembly can conveniently be switched in vitro by addition or removal of ATP. Experiments on the disassembly kinetics of filaments in ATP have led us to the conclusion that growth and shortening of filaments occurs essentially only from the filament ends (Fig. 2) .
How does light chain phosphorylation regulate assembly?
The data in vitro indicate that incubating smooth muscle and non-muscle myosin filament-monomer solutions with activated myosin light chain kinase leads to phosphorylation of the myosin population and net assembly of filaments; whereas incubation with phosphatase dephosphorylates the myosin and produces net filament disassembly. Most previous experiments have been carried out at about 1 mg unphosphorylated myosin/ml or less, which is well below the critical concentration for assembly of these unphosphorylated myosins in ATP. This has meant that phosphorylation has made filaments appear and dephosphorylation has made them disappear. Working at higher myosin concentrations, it is apparent that the real action of phosphorylation is to change the concentration of free monomer present in equilibrium with the filaments (Le. to change the critical concentration for assembly). For example, at physiological ionic strength and in the presence of ATP, the equilibrium free monomer concentration drops upon phosphorylation for gizzard myosin from 10 p~ to 1 PM, and for brush border myosin from 2.5 ,UM to 0.4 ,LAM (Kendrick-Jones et al., 1987) . There is electron microscopic evidence that phosphorylation results in a net transformation of free 10s monomers into free 6s monomers (Craig et a[., 1983) . We believe that the net effect of phosphorylation/dephosphorylation on the state of filament assembly is due to these perturbations in the 10s-6s equilibrium, as follows.
Myosin Fig. 2 . Disassembly of irtiphosphorylated myosin filaments by A TI' Total myosin concentration 0.3 mg/ml. Buffer: 150 mM-KCI, 10 mM-imidazole, 1 m~-M g C l~, 0.5 mM-EGTA, 0.5 mM-DTT, pH 7.3 (21°C). The length distribution (inset) was determined by electron microscopy. Disassembly was monitored using the transmission of light at 340 nm. The data are well fit by a single exponential (continuous line). For a length distribution of this form, this indicates that disassembly occurs by sequential loss of protomers from the filament ends (Purich et al., 1985) . Sobieszek, 1985) . Since 6s free monomers are at low concentration at equilibrium, the major target for kinase must be myosin filaments. According to the model, phosphorylated myosin will gradually exchange from phosphorylated filaments into the 6s monomer pool. Folding of these phosphorylated 6s monomers is unfavourable under physiological conditions, so that entry of monomers to the 1 0 s pool is essentially blocked. 1 0 s molecules, however, continue spontaneously to unfold into the 6s form. The 10s pool therefore depopulates, and net filament assembly follows.
BIOCHEMICAL SOCIETY TRANSACTIONS
As yet there is no evidence for an effect of phosphorylation on the filaments-6S exchange reactions. As shown below, we can specifically mimic the effect of regulatory light chain phosphorylation by perturbing only the 6s-1 0 s monomer equilibrium.
Use of monoclonal antibodies to perturb the assembly equilibria: mimicking the effects of phosphotylution Monoclonal antibodies binding to specific regions of the myosin tail have proved to be useful probes for analysing filament assembly in epithelial brush border myosin (Citi & Kendrick-Jones, 19876) .
Antibodies bind to the tip of the tail block assembly, demonstrating the importance of this region for the initial steps in assembly. They probably inhibit formation of the antiparallel dimer which is thought to be the building block for these filaments (Craig & Megerman, 1977; Hinssen et al., 1978) . Interestingly these antibodies also inhibit actomyosin ATPase activity, indicating a correlation between the inhibition of filament assembly and that of contraction. Antibodies binding to sites about one-third and two-thirds of the way along the myosin tail partially block assembly, and structural intermediates are formed, whose length and packing depend on the position of the antibody binding site on the tail. One of these antibodies also prevents the molecule from forming the 10s conformation (Citi & Kendrick-Jones, 1 9 8 7~) .
Using this antibody we have been able to manipulate the free monomer population exactly to mimic the effects of regulatory light chain phosphorylation on the myosin assembly reaction ( A monoclonal binding at the tip of the tail blocks filament assembly (upper box), while one which binds at the head-tail contact site blocks formation of the 10s conformation.
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625th MEETING, LONDON 3). These experiments confirm our belief that it is the creation and destruction of a pool of 10s molecules which is the key event regulating filament assembly-disassembly in these myosins.
Concluding comments
How might these findings relate to the regulation of motility in vertebrate non-muscle and smooth muscle cells? We believe that in these cells, myosin exists in a dynamic equilibrium between primarily filaments and a 10s monomer pool. 6s monomers and/or dimers are transiently stable, and present only at low concentrations at steady state. The position of the equilibrium between 10s and filaments defines the critical free monomer concentration for assembly. The action of regulatory light chain phosphorylation is to decrease this critical concentration 5-10 fold, thus promoting filament assembly from the 1 0 s monomer pool. Conversely, dephosphorylation favours filament disassembly, and the associated repopulation of the 1 0 s monomer pool. Myosin light chain kinase probably acts predominantly on actin-associated myosin, since it binds to actin as well as myosin (Delanerolle et al., 1981; Yamazaki et a[., 1987) . In this way the actin cytoskeleton could act as a framework for myosin assembly, the polarity of the actin defining the polarity of the myosin, and thereby determining the direction of contractile movement.
There are major differences between the regulation of vascular and cardiac muscle at the level of the contractile proteins, the regulation of cytoplasmic Ca2+, and the control by intracellular second messengers. The other contributors to this colloquium discuss in considerable detail the current state of knowledge of regulation of smooth muscle. In this article the emphasis will be placed on the regulation of cardiac muscle contraction, and how this differs from that in smooth muscle.
Myofibrillar regulation
At the level of the myofibril the acute regulation of cardiac contraction by Ca2+ is exclusively via the thin filament, in contrast to the regulation of smooth muscle which is through both thick and thin filaments (Marston et al., 1988; Cross et al., 1988) . Cardiac thin filaments contain the Ca2+-binding troponin complex (Ebashi, 1980) , which confers Ca2+ sensitivity on the interaction between actin and myosin. The complex is composed of three subunits: troponin-C, the Ca2+-binding subunit sharing a high degree of sequence homology with calmodulin; troponin-I, the inhibitory subunit which by itself inhibits actin-myosin interactions and Abbreviations used: LC-2, myosin regulatory light chain; MLCK, myosin light chain kinase; S.R., sarcoplasmic reticulum; Ins( 1 ,4,5)P3, inositol 1,4,5-trisphosphate; cA-PrK, cyclic-AMPdependent protein kinase. troponin-T, the tropomyosin-binding subunit. Certain analogies may be drawn between this system in cardiac muscle and the caldesmon system in smooth muscle, although the proteins involved are somewhat different. Thus caldesmon inhibits the interaction between actin and myosin in a Ca2+-independent manner (Sobue et a [., 1981; Marston et al., 1988) , similar to the effects of troponin-I. However, one striking difference is that whereas the ratio of troponin-I to actin in cardiac muscle is 1 : 7, the ratio of caldesmon to actin in smooth muscle thin filaments is 1:28 (Marston et al., 1988) . Ca2+ sensitivity in both these systems is conferred by additional proteins, troponin-C in the case of cardiac muscle, calmodulin or other undefined Ca2 +-binding proteins for smooth muscle. Since both cardiac and smooth muscle thin filaments contain tropomyosin, similar structural changes in the thin filament probably occur on Ca2+ binding, permitting cross-bridge attachment and force generation.
One of the fundamental mechanisms for the control of smooth muscle contraction is the phosphorylation of the myosin regulatory light chain (LC-2) by the Ca2 + -dependent myosin light chain kinase (MLCK) (Kamm & Stull, 1985; Marston et al., 1988; Cross et al., 1988) . In the absence of LC-2 phosphorylation there is very little interaction between smooth muscle myosin and actin, and for at least the initiation of smooth muscle contraction, phosphorylation of LC-2 appears to be obligatory. In cardiac muscle the role of LC-2 phosphorylation is contentious, the consensus being that there is little or no effect of LC-2 phosphorylation on the kinetics of actin-myosin interaction. Cardiac muscle does contain both MLCK and a light chain phosphatase (Frearson & Perry, 1975) , although only at low activities. In isolated Vol. 16
